Our review is based on the papers published during last the 20 years and its aim is to systematize the knowledge about the E-cadherin expression in the primary ovarian tumor tissue in relation to the clinicopathological parameters and epithelial ovarian cancer (EOC) patients’ survival. This evidence concerns the gene CDH1 and ovarian carcinoma.